Trends in Belgian Premature Avoidable Deaths over a 20 Year Period

Overview

Journal J Epidemiol Community Health

Specialty Health Services

Date 2000 Aug 15

PMID 10942448

Citations 14

Authors

P C Humblet

R Lagasse

A Leveque

Affiliations

Soon will be listed here.

Abstract

Study Objectives: To analyse over a 20 year period the level and trends in the "EC avoidable death indicators".

Design: The Years of Potential Life Lost (YPLL) method applied to curative and preventive avoidable mortality indicators in Belgium for four successive five year periods, countrywide as well as by district, separately for women and men. Ratios of YPLL rates (age standardised) describe changes between 1974-78 and 1990-94.

Setting: Belgium for the periods 1974-78, 1980-84, 1985-89, 1990-94.

Participants: All avoidable death cases aged 1-64.

Main Results: Ratio of YPLL rates indicated a more favourable development between 1974-78 and 1990-94 in the EC avoidable indicators than in all causes premature mortality. The EC avoidable mortality indicators have been assigned to two categories, curative indicators and preventive indicators. The best ratio of YPLL rates was found in curative indicators for men but the largest gains in YPLL rates over the periods come from the "preventive indicators" in men. For women, malignant neoplasm of the breast rose to the first ranked in 1985-1989 and 1990-1994, where it contributed to more years of YPLL loss than motor vehicle accidents, and malignant neoplasm of the trachea, bronchus and lung had risen to the fifth ranked since 1985-89. The order of the top causes for men did not change between 1974 and 1994, except for cirrhosis of liver, which rose from the fifth to the fourth rank. In the particular case of one "preventive indicator", malignant neoplasm of the trachea, bronchus and lung, the regional analysis of time trend between 1974-78 and 1990-94 showed more districts with a favourable development for both men and women in the Flemish region than in Wallonia.

Conclusion: The YPLL method combined with the avoidable mortality indicators enabled us to compare the changes of curative and preventive EC avoidable indicators between 1974-78 and 1990-94. In the case of malignant neoplasm of the trachea, bronchus and lung, which is of major concern to the health promotion policies, changes over the periods have widened a "north/south" health contrast.

Citing Articles

Avoidable Mortality in Korea 1997-2001: Temporal Trend and its Contribution to All-cause Mortality.

Jeong Y, Seo S Int J Public Health. 2024; 69:1606825.

PMID: 38978831 PMC: 11228162. DOI: 10.3389/ijph.2024.1606825.

The burden of premature mortality from cardiovascular diseases: A systematic review of years of life lost.

Hasani W, Muhamad N, Hanis T, Maamor N, Wee C, Omar M PLoS One. 2023; 18(4):e0283879.

PMID: 37083866 PMC: 10121009. DOI: 10.1371/journal.pone.0283879.

Avoidable Mortality between Metropolitan and Non-Metropolitan Areas in Korea from 1995 to 2019: A Descriptive Study of Implications for the National Healthcare Policy.

Choi M, Moon M, Yoon T Int J Environ Res Public Health. 2022; 19(6).

PMID: 35329162 PMC: 8955663. DOI: 10.3390/ijerph19063475.

Avoidable Mortality: The Core of the Global Cancer Divide.

Knaul F, Arreola-Ornelas H, Rodriguez N, Mendez-Carniado O, Kwete X, Puentes-Rosas E J Glob Oncol. 2018; 4:1-12.

PMID: 30096010 PMC: 6223530. DOI: 10.1200/JGO.17.00190.

Site-specific cancer mortality inequalities by employment and occupational groups: a cohort study among Belgian adults, 2001-2011.

Vanthomme K, Van den Borre L, Vandenheede H, Hagedoorn P, Gadeyne S BMJ Open. 2017; 7(11):e015216.

PMID: 29133313 PMC: 5695485. DOI: 10.1136/bmjopen-2016-015216.

References

RUTSTEIN D, BERENBERG W, CHALMERS T, CHILD 3rd C, Fishman A, PERRIN E . Measuring the quality of medical care. A clinical method. N Engl J Med. 1976; 294(11):582-8. DOI: 10.1056/NEJM197603112941104. View

Romeder J, McWhinnie J . Potential years of life lost between ages 1 and 70: an indicator of premature mortality for health planning. Int J Epidemiol. 1977; 6(2):143-51. DOI: 10.1093/ije/6.2.143. View

Charlton J, Hartley R, Silver R, Holland W . Geographical variation in mortality from conditions amenable to medical intervention in England and Wales. Lancet. 1983; 1(8326 Pt 1):691-6. DOI: 10.1016/s0140-6736(83)91981-5. View

Woolhandler S, Himmelstein D, Silber R, Bader M, Harnly M, Jones A . Medical care and mortality: racial differences in preventable deaths. Int J Health Serv. 1985; 15(1):1-22. DOI: 10.2190/90P3-LEFF-WNU0-GLY6. View

Humblet P, Lagasse R, Moens G, Wollast E, VAN DE VOORDE H . [Avoidable mortality in Belgium]. Soc Sci Med. 1987; 25(5):485-93. DOI: 10.1016/0277-9536(87)90172-9. View

Mackenbach J, Bouvier-Colle M, Jougla E . "Avoidable" mortality and health services: a review of aggregate data studies. J Epidemiol Community Health. 1990; 44(2):106-11. PMC: 1060615. DOI: 10.1136/jech.44.2.106. View

Boys R, Forster D, Jozan P . Mortality from causes amenable and non-amenable to medical care: the experience of eastern Europe. BMJ. 1991; 303(6807):879-83. PMC: 1671237. DOI: 10.1136/bmj.303.6807.879. View

Westerling R, SMEDBY B . The European Community 'avoidable death indicators' in Sweden 1974-1985. Int J Epidemiol. 1992; 21(3):502-10. DOI: 10.1093/ije/21.3.502. View

Westerling R . Trends in "avoidable" mortality in Sweden, 1974-1985. J Epidemiol Community Health. 1992; 46(5):489-93. PMC: 1059638. DOI: 10.1136/jech.46.5.489. View

10.

Ortega A, Puig M . Influence of different upper age limits on the "Years of Potential Life Lost" index. Eur J Epidemiol. 1992; 8(6):875-7. DOI: 10.1007/BF00145336. View

11.

Pampalon R . Avoidable mortality in Québec and its regions. Soc Sci Med. 1993; 37(6):823-31. DOI: 10.1016/0277-9536(93)90376-f. View

12.

Westerling R . Indicators of "avoidable" mortality in health administrative areas in Sweden 1974-1985. Scand J Soc Med. 1993; 21(3):176-87. DOI: 10.1177/140349489302100307. View

13.

Westerling R . Components of small area variation in death rates: a method applied to data from Sweden. J Epidemiol Community Health. 1995; 49(2):214-21. PMC: 1060110. DOI: 10.1136/jech.49.2.214. View

14.

Gaizauskiene A, Gurevicius R . Avoidable mortality in Lithuania. J Epidemiol Community Health. 1995; 49(3):281-4. PMC: 1060798. DOI: 10.1136/jech.49.3.281. View

15.

Gaizauskiene A, Westerling R . A comparison of avoidable mortality in Lithuania and Sweden 1971-1990. Int J Epidemiol. 1995; 24(6):1124-31. DOI: 10.1093/ije/24.6.1124. View

16.

Albert X, Bayo A, Alfonso J, Cortina P, Corella D . The effectiveness of health systems in influencing avoidable mortality: a study in Valencia, Spain, 1975-90. J Epidemiol Community Health. 1996; 50(3):320-5. PMC: 1060290. DOI: 10.1136/jech.50.3.320. View

17.

Westerling R . Can regional variation in "avoidable" mortality be explained by deaths outside hospital? A study from Sweden, 1987-90. J Epidemiol Community Health. 1996; 50(3):326-33. PMC: 1060291. DOI: 10.1136/jech.50.3.326. View

18.

McDonnell S, Vossberg K, Hopkins R, Mittan B . Using YPLL in health planning. Public Health Rep. 1999; 113(1):55-61. PMC: 1308369. View

19.

Levi F, Lucchini F, La Vecchia C, Negri E . Trends in mortality from cancer in the European Union, 1955-94. Lancet. 1999; 354(9180):742-3. DOI: 10.1016/S0140-6736(99)01909-1. View

20.

Leveque A, Coppieters Y, Piette D . Belgium and statistics on mortality. Lancet. 1999; 354(9180):779. DOI: 10.1016/S0140-6736(05)76023-2. View